RAPT Therapeutics, Inc.
RAPT
$0.7479
-$0.1309-14.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.30% | -11.19% | 1.27% | -21.97% | -27.43% |
| Total Depreciation and Amortization | -7.31% | -1.07% | 8.21% | 17.31% | 13.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.39% | 49.28% | 54.96% | 42.62% | 11.07% |
| Change in Net Operating Assets | -249.20% | 371.12% | -462.25% | -59.79% | -179.07% |
| Cash from Operations | -2.93% | 14.17% | -9.19% | -19.98% | -43.00% |
| Capital Expenditure | 87.26% | 89.16% | 83.02% | 78.88% | 67.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -121.21% | -49.81% | 71.64% | 4,086,350.00% | 323.62% |
| Cash from Investing | -121.38% | -49.39% | 75.69% | 7,349.82% | 315.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,287.25% | 10,463.37% | -86.65% | -87.36% | -92.10% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,287.25% | 10,463.37% | -86.65% | -87.36% | -92.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,412.64% | 1,332.92% | -161.43% | -85.92% | -103.38% |